OncoSil Medical Ltd (OSL):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:OncoSil Medical Ltd (OSL) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7368
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥68,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥102,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
OncoSil Medical Ltd (OncoSil), formerly Neuro Discovery Ltd, is a medical device company that develops and commercializes products for the treatment of pancreatic and liver cancer. The company’s lead product includes oncosil, a brachytherapy device that emits beta radiation and is implanted directly inside the cancerous tumor during an endoscopic ultrasound guidance procedure. It offers various treatment options for patients with pancreatic cancer including surgery, external radiation therapy, chemotherapy, and chemo-radiation therapy. The company undertakes clinical studies to investigate the clinical benefit of oncosil in when used in combination with standard of care chemotherapy. OncoSil is headquartered in Sydney, New South Wales, Australia.

OncoSil Medical Ltd (OSL) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
OncoSil Medical Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
OncoSil Medical Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
OncoSil Medical Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
OncoSil Medical Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
OncoSil Medical Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
OncoSil Medical Ltd, Medical Equipment, Deal Details 10
Equity Offering 10
OncoSil Medical Raises USD3.1 Million in Rights Offering of Shares 10
OncoSil Medical Raises USD6.7 Million in First Tranche Private Placement of Shares 11
OncoSil Medical Completes Rights Offering Of Shares For US$1 Million 12
OncoSil Medical Completes Private Placement Of Shares For US$7.3 Million 13
Oncosil Medical Completes Private Placement Of Shares For US$0.2 Million 14
Acquisition 15
NeuroDiscovery Acquires Enigma Therapeutics, Cancer Product Manufacturer 15
OncoSil Medical Ltd – Key Competitors 16
OncoSil Medical Ltd – Key Employees 17
OncoSil Medical Ltd – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Corporate Communications 19
Sep 25, 2017: OncoSil Medical: Receipt of $2.9m R&D Tax Incentive Refund 19
Other Significant Developments 20
Jul 31, 2017: OncoSil Medical: CE Mark & Quarterly Activity Update Quarter ended 30 June 2017 20
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
OncoSil Medical Ltd, Medical Equipment, Key Facts, 2018 2
OncoSil Medical Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
OncoSil Medical Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
OncoSil Medical Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
OncoSil Medical Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
OncoSil Medical Ltd, Deals By Market, 2012 to YTD 2018 8
OncoSil Medical Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
OncoSil Medical Raises USD3.1 Million in Rights Offering of Shares 10
OncoSil Medical Raises USD6.7 Million in First Tranche Private Placement of Shares 11
OncoSil Medical Completes Rights Offering Of Shares For US$1 Million 12
OncoSil Medical Completes Private Placement Of Shares For US$7.3 Million 13
Oncosil Medical Completes Private Placement Of Shares For US$0.2 Million 14
NeuroDiscovery Acquires Enigma Therapeutics, Cancer Product Manufacturer 15
OncoSil Medical Ltd, Key Competitors 16
OncoSil Medical Ltd, Key Employees 17

List of Figures
OncoSil Medical Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
OncoSil Medical Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
OncoSil Medical Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
OncoSil Medical Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
OncoSil Medical Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
OncoSil Medical Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
OncoSil Medical Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
OncoSil Medical Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[OncoSil Medical Ltd (OSL):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ameren Corporation:企業の戦略・SWOT・財務情報
    Ameren Corporation - Strategy, SWOT and Corporate Finance Report Summary Ameren Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • AAK AB:企業の戦略・SWOT・財務情報
    AAK AB - Strategy, SWOT and Corporate Finance Report Summary AAK AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Union Pacific Corporation:企業の戦略・SWOT・財務情報
    Union Pacific Corporation - Strategy, SWOT and Corporate Finance Report Summary Union Pacific Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • NeoTract Inc:医療機器:M&Aディール及び事業提携情報
    Summary NeoTract Inc (NeoTract) is a medical device company that designs and develops minimally invasive devices for use in the field of urology. The company’s urolift system is designed to treat lower urinary tract symptoms caused by benign prostatic hyperplasia. It partners with its customers to i …
  • Century Enka Limited:企業の戦略・SWOT・財務分析
    Century Enka Limited - Strategy, SWOT and Corporate Finance Report Summary Century Enka Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Stater Bros. Markets:企業の戦略・SWOT・財務情報
    Stater Bros. Markets - Strategy, SWOT and Corporate Finance Report Summary Stater Bros. Markets - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Akers Biosciences Inc (AKER):企業の財務・戦略的SWOT分析
    Summary Akers Biosciences Inc (ABI) is a medical device company that develops, manufactures and supplies point-of-care screening and testing products. The company provides clinical diagnostics, safety diagnostics, and wellness products. ABI products include BreathScan alcohol detectors, CHUBE, METRO …
  • Kesko Corporation:企業の戦略・SWOT・財務情報
    Kesko Corporation - Strategy, SWOT and Corporate Finance Report Summary Kesko Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Coastal Contacts Inc-医療機器分野:企業M&A・提携分析
    Summary Coastal Contacts Inc (Coastal Contacts), a subsidiary of Essilor International is an online retailer that markets eye care products. The company's products include eyeglasses, contact lenses, sunglasses, vision care accessories, and others. Its contact lenses comprise daily wear colour lense …
  • Morcher Gmbh:企業の製品パイプライン分析2018
    Summary Morcher Gmbh (Morcher) is a medical device company that develops, manufactures, and distributes implants for cataract surgery. The company’s products include capsular tension rings, eyejet ctr - preloaded capsular tension rings, cionni rings for scleral fixation, capsular segment for scleral …
  • Reliance Naval and Engineering Ltd:企業のM&A・事業提携・投資動向
    Reliance Naval and Engineering Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Reliance Naval and Engineering Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on m …
  • Sunesis Pharmaceuticals Inc (VIRX):企業の財務・戦略的SWOT分析
    Sunesis Pharmaceuticals Inc (VIRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • ImmunoGen Inc (IMGN):製薬・医療:M&Aディール及び事業提携情報
    Summary ImmunoGen Inc (ImmunoGen) is a clinical-stage biotechnology company that focuses on the development of antibody-drug conjugate therapies for the treatment of cancer. The company’s lead product candidate, mirvetuximab soravtansine, a folate receptor alpha (FRa) intended for the treatment of p …
  • Nanosphere Inc-医療機器分野:企業M&A・提携分析
    Summary Nanosphere Inc (Nanosphere) a subsidiary of Cepheid is a medical device company that develops molecular diagnostic tests for disease detection and patient treatment. The company’s products comprise verigene system, instrumentation, bloodstream infection tests, gastrointestinal infection test …
  • Cytokinetics Inc (CYTK):製薬・医療:M&Aディール及び事業提携情報
    Summary Cytokinetics Inc (Cytokinetics) is a late stage biopharmaceutical company, which discovers, develops, and commercializes muscle activators for the treatment of diseases associated with reduced muscle performance. The company’s pipeline encompasses omecamtiv mecarbil, a novel cardiac myosin a …
  • Capital Senior Living Corp (CSU):製薬・医療:M&Aディール及び事業提携情報
    Summary Capital Senior Living Corp (Capital Senior Living) is engaged in providing residential communities for elderly population. The company offers various living accommodations and supportive services including senior living services, independent living services, assisted living services includin …
  • Sysco Corporation (SYY):企業の財務・戦略的SWOT分析
    Sysco Corporation (SYY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Latvenergo AS-エネルギー分野:企業M&A・提携分析
    Summary Latvenergo AS (Latvenergo) is a state-owned power supply utility company that generates and supplies electricity and thermal energy, distributes electricity, leases transmission system assets. It generates electricity through various renewable energy sources such as hydropower, biomass, wind …
  • Mayne Pharma Group Ltd (MYX):企業の財務・戦略的SWOT分析
    Summary Mayne Pharma Group Ltd (Mayne Pharma), formerly HalcyGen Pharmaceuticals Ltd, a subsidiary of Mayne Pharma Group Ltd, is a specialty pharmaceutical company that manufactures and markets branded and generic medicinal products. The company’s products comprise erymax capsules, kapanol capsules, …
  • Finley Resources Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Finley Resources Inc (Finley) is an oil and gas company that owns, manages, operates and develops oil and gas properties. The company operates its oil and gas properties in the areas of Permian Basin, South Texas, East Texas, Mississippi, Barnett Shale, San Juan Basin, Alabama, Oklahoma and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆